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Abstract
Background: Individuals with fragile X syndrome (FXS) typically demonstrate profound executive function (EF)
deficits that interfere with learning, socialization, and emotion regulation. We completed the first large, non-
pharmacological controlled trial for FXS, designed to evaluate the efficacy of Cogmed, a computer/tablet-based
working memory (WM) training program.
Methods: The study was a randomized, blinded, parallel two-arm controlled trial in 100 children and adolescents
with FXS (63 male, 37 female; 15.28 ± 3.36 yrs.). Participants were randomized equally to adaptive (difficulty level
adjusted to performance) or non-adaptive (control) Cogmed training. Participants were assessed at home using
objective measures of WM (primary outcome) and EF at baseline, following 20–25 caregiver-supported sessions
over 5–6 weeks, and at follow-up 3 months after cessation of training. Parents and teachers provided ratings of WM,
attention, and EF.
Results: The WM composite and selective domains of EF (distractibility, cognitive flexibility), as well as parent- and
teacher-reported attention and EF, significantly improved across the full study sample, with many changes
maintained at follow-up. However, comparisons of improvement between adaptive and non-adaptive
control conditions did not differ, showing that progressively challenging the WM system by expanding span length
did not provide added benefit overall.
Conclusions: Further experimental comparisons are needed before Cogmed working memory training can be
considered empirically validated for children with FXS, forming the basis of treatment recommendation. However,
given that prior studies show no significant changes on these measures in FXS without treatment, that
improvements were maintained for 3 months, and that blinded teachers reported improvements in the classroom,
the modest benefits seen in both adaptive and non-adaptive groups overall are unlikely to be attributable to
placebo or practice effects alone. Future analyses examining inter-individual differences (e.g., baseline capacity,
training efficiency, co-morbidity, training environment, characteristics of training aide) may help to link this
intervention to outcomes and potential transfer effects.
Trial registration: US National Institutes of Health (ClinicalTrials.gov), NCT02747394.
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Background
Fragile X syndrome (FXS) is caused by a so-called “full
mutation” in the fragile X mental retardation 1 (FMR1)
gene at Xq27.3 and occurs in an estimated 1 of every
2500 to 5000 live births [1]. It is the most common
inherited cause of intellectual disability, and over 90% of
males and 30–50% of females with the full mutation
have IQ scores in this range (IQ < 70) [2]. The cognitive
phenotype of FXS is characterized by prominent deficits
in executive function (EF), including problems with
working memory (WM) [3–5], inhibitory control [4–7],
cognitive flexibility/perseveration [6, 7], and selective
and divided attention [7–9]. Most of these deficits have
been documented in both controlled neuropsychological
studies as well as brain functional magnetic resonance
imaging (fMRI) studies showing abnormalities in
frontal-striatal circuits [10].
There has been rapid progress in the development of
several potentially disease-modifying targeted pharmaco-
logical agents, developed through extensive research on
the fragile X animal models (Fmr1 knockouts; for review
see [11]). These discoveries paved the way for treatment
of the underlying neurobiology of the disorder in
humans, including controlled trials of mGluR5 negative
modulators, ganaxolone, minocycline, the ampakine
CX516, and the cholinergic agonist, donepezil (see re-
view by Berry-Kravis [12]). However, there has been little
if any evidence to date that these medications alone can
improve behavior or lead to cognitive improvements in
this population. As such, effective cognitive and behav-
ioral treatments can fill an important gap in this clinical
research space and could represent an empirically sup-
ported intervention for families to consider.
Torkel Klingberg and his colleagues at Karolinska
Institute showed in a series of studies that WM cap-
acity can be increased with intensive training [13–18].
Stemming from the success of their initial studies,
these researchers developed a program that became
the basis for the Cogmed computer-based WM train-
ing. The training program consists of several different
computerized visuospatial memory training tasks, in-
volving the temporary storage (and sometimes ma-
nipulation) of sequences in a game format
appropriate for the individual’s developmental level.
Training success depends in part on visual attention
(to encode the sequence of animated figures) and re-
sponse inhibition (to wait to respond until the se-
quence is complete), two aspects of executive
function that are especially impaired by FXS. Cogmed
is likely the most researched cognitive training pro-
gram, with over 80 original, peer-reviewed research
articles (Cogmed Claims and Evidence; https://www.
cogmed.com/). Randomized, double-blind, placebo
controlled studies documented that Cogmed and
other WM training procedures may improve WM and
academic achievement, reduce symptoms in children
with ADHD, increase auditory attention and WM in
preschool children, and improve inattention in daily
life (see a review of published studies at https://www.
cogmed.com/). However, about the time that the
current project was designed and initiated, the effi-
cacy and generalizability of WM training came under
considerable scrutiny, with some investigators con-
cluding that “there is little evidence that these pro-
grams are suitable as methods of treatment for
children with developmental cognitive disorders” and
citing limitations of the research, such as the lack of
methodological consistency between studies [19–21]
and concerns about generalization beyond the training
tasks (i.e., far-transfer effects) [20–22]. However, a
subsequent "review of reviews" contradicts some of
the conclusions [23]. Part of contradictory findings
may lie in the theoretical approach with Shipstead ar-
guing that with cognitive training in working memory
[21], one should expect to see improvement in gen-
eral cognitive processes (c.f., [24, 25]). Shipstead et al.
nicely detail recommendations for designing studies
in order to evaluate the meaningfulness of cognitive
training interventions. They include (1) use of multiple
measures to assess the broad effect of training on
functioning, (2) measure near-transfer effects with
valid tools assessing working memory capacity, (3)
use control groups that include contact with the ex-
perimenters, and (4) use raters blind to study condi-
tion for subjective measures. The current project
attempted to address concerns raised by Shipstead et
al. [21], although this project differs from many of
those cited by Shipstead [21] in that our assumption
was that working memory training would improve a
narrow range of cognitive and behavioral processes
associated with impairments in FXS, rather than
broad cognitive functioning. We also make the as-
sumption that there is greater plasticity in
pediatric-aged participants than in the older adults
cited in other commentaries critical of cognitive train-
ing [24].
Until our preliminary feasibility study [26], working
memory training had not been previously applied to or
evaluated in persons with FXS. However, Bennett et al.
[27] evaluated and demonstrated the feasibility and pre-
liminary efficacy of Cogmed JM in children with Down
syndrome (DS). In the study, 25 children between the
ages of 7 and 12 (mean = 9.6 years) and with a mental
age between 4 and 7 years (Mean IQ = 65) were random-
ized into the Cogmed intervention or a waitlist control
group. The group completed training in the school set-
ting, facilitated by a special education teaching assistant,
3 times per week for 13 weeks (on average 8.6 h of active
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training), including feedback and support. The children
completed pre- and post-training assessments using the
Cogmed-based Index of Improvement (difference in vis-
ual memory span from the first 3 training sessions and
the highest span achieved during training), non-trained
working memory tasks [verbal short-term memory,
counting recall, dot matrix, and visual-spatial working
memory from the Automated Working Memory Assess-
ment (AWMA)], and parent report of executive func-
tioning. The Down syndrome participants undergoing
training had mean span scores of 3.18–3.53 across
games at start and mean span scores of 4.09–4.62 at the
highest point, with a mean Cogmed Index of Improve-
ment of 14.30. While the wait-listed group of children
with DS showed no significant changes, the Cogmed
group showed significant improvement on all Cogmed
tasks, visual-spatial working memory tasks, and parent
ratings of cognitive flexibility and working memory.
However, as the authors noted, the study was limited by
the wait-list comparison which could not provide blind-
ing or a placebo condition. With the understanding of
mixed scientific opinion of the efficacy of these methods,
but the conviction that well-standardized and
data-driven learning and cognitive training paradigms
need to be rigorously studied for FXS, we committed to
a trial of Cogmed, the most well-established and investi-
gated program available.
The study aim was to evaluate the efficacy of adaptive
Cogmed training (compared to non-adaptive Cogmed) to
enhance WM and EF in children and adolescents with
FXS in a controlled, randomized, triple-blinded (partici-
pant, care provider, outcomes assessor) trial. The primary
hypothesis was that individuals with FXS who engage in
25 sessions of adaptive Cogmed training over a period of
5–6 weeks will demonstrate significant improvement on
objective, non-trained measures of WM, attention, and in-
hibitory control compared to those receiving non-adaptive
(control) but otherwise identical training.
Methods
Participants and randomization
This study was registered at the clinicaltrials.gov website
with identifier NCT02747394. Inclusion criteria were
FMR1 full mutation, as determined by DNA testing, 8–
18 years of age, normal or corrected to normal vision
and hearing, ability to pass at least some three-span
items during a Cogmed training session at baseline, Eng-
lish or Spanish speaking, and parental agreement to
maintain adherence to the training schedule and to not
alter other treatments during the study. The exclusion
criteria were significant brain trauma, previous Cogmed
training and significant medical or severe behavioral
problems that would interfere with the study. The ex-
perimental group completed the usual, publicly available
Cogmed adaptive training. For the adaptive version, the
difficulty level increases when the participant answers
correctly and eases when he or she answers incorrectly
and thus memory span is continuously challenged. For
the control condition, we chose a non-adaptive version
of Cogmed where the span length stays fixed at two
throughout all tasks for all sessions and thus memory
span is less challenged. Memory span was constrained at
2 span for control training because for many participants
with FXS and intellectual disability, 3 or 4 span is the
maximum they can achieve at baseline and we wanted
to ensure that the span level for the non-adaptive con-
trol condition was feasible and would clearly differenti-
ate the groups on level of difficulty. Otherwise these
versions are identical. We considered a wait-list control
condition but decided against it as this would only allow
a comparison of the intervention to no treatment, a less
rigorous design [21] lacking specificity (e.g., significant
gains in adaptive training compared to wait-list could be
attributed to simply playing any computer “game”, the
result of the families receiving significant attention from
experimenters, or added structure of daily activity). See
the Consolidated Standards of Reporting Trials (CON-
SORT) diagram (Fig. 1) for details of study participants,
randomization, and retention. The first participant was
enrolled in April 2012 and the last was completed in De-
cember 2017. Regarding the 25 participants who were
excluded, reasons varied greatly, but the most common
were age outside of range, inability to do at least some 3
span items correctly at baseline, and severe behavioral
problems.
The final sample of 100 participants, residing in loca-
tions throughout the U.S. and Canada (Additional file 1:
Figure S1) included 37 females (7 adaptive JM, 5
non-adaptive JM; 11 adaptive RM and 14 non-adaptive
RM) and 63 males (25 adaptive JM, 27 non-adaptive JM;
7 adaptive RM, 4 non-adaptive RM). Prior to the study,
we determined that for a moderate effect size of 0.6
(standardized difference between groups), the planned
analysis of covariance (ANCOVA) with n = 100 partici-
pants would have power between 87% and 93% when
the correlation between baseline and six-week measure-
ments ranges from 0.25 to 0.5 (two-sided test at level
alpha = 0.05). The expected effect size of 0.6 is consistent
with those reported in prior Cogmed trials, including those
involving an intellectually disabled population (DS [27]). As-
signment to RM (school-age version suitable for higher
functioning participants; see details below) vs. JM (preschool
version suitable for lower functioning participants; see de-
tails below) was determined based on screening, baseline
cognitive testing, clinical judgment, and ability to under-
stand and complete RM games. Participants who were high
functioning enough and could complete at least 11 of 13
RM games at baseline during the first visit were assigned to
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RM. In the adaptive group, all 50 participants (100%) were
adherent to treatment (20–25 days of training, mean =
24.22 days) and in the non-adaptive group 49/50 (98%) were
adherent (1 participant with 18 training days, mean = 24.22
days).
The Cogmed training program
Cogmed JM, intended for preschool age children and
based on an amusement park theme, consists of seven
different computerized visuospatial memory training
tasks. Each task involves the temporary storage and, for
some tasks, manipulation of visuospatial sequences. For
example, bumper cars that move around the screen and
light up one at a time are recalled in order by the par-
ticipant who either clicks with the computer mouse or
touches the cars on the screen. Four of the seven tasks
involve only the storage of visual information (pool,
hotel, rollercoaster, twister), two involve both manipulat-
ing and storage of visual information (Ferris wheel,
bumper cars), and one involves the storage of visual and
auditory information (wheel of animals). In each training
session, participants completed three of the seven train-
ing activities. Sessions typically require 15 min. Cogmed
RM is intended for school-age children above 7 years,
lasts about 30 min per session, and includes 14 different
tasks centered on a robot theme. The tasks are more
complex and challenging than JM, involving rotating dis-
plays, moving targets, reverse sequence tasks, numeric
information to recall, and delayed responses. Each ver-
sion of Cogmed (adaptive JM and RM) provides an
Index of Improvement metric, defined as the difference
in average visual memory span from the first 3 training
sessions (across tasks) and the current highest average
span achieved during training.
Study procedures
After primary inclusion criteria were satisfied, an
examiner traveled to the home to consent/assent and
collect baseline data. (Examiners and Cogmed coaches
were different staff members so that the examiners
were kept blind to treatment condition.) During the
first visit, the examiner completed baseline assess-
ments (Time 1), worked with participants briefly on
the Cogmed RM game “asteroids” to ensure capacity
for 3 span training, and worked with the parents on
how to support participants during training sessions
(e.g., positive reinforcement, visual schedules, reward
chart) and to ensure that the training location was
optimal. Following completion of baseline assess-
ments, participants were randomized (using a random
Fig. 1 CONSORT diagram showing study screening, enrollment, randomization, retention, and final sample sizes
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number generator) equally to one of two groups: (1)
adaptive Cogmed or (2) non-adaptive Cogmed (con-
trol). The group assignment was concealed from the
staff conducting the study. All participants maintain-
ing active enrollment in the study had no change in
treatment (pharmacological, behavioral) during the
course of the training period. Parent training aides
and teacher raters were kept blind to treatment
group, and parents were asked to inform teachers that
their children are in a research study and to avoid
any mention of treatment. The examiners explained to
the caregivers that the study is comparing two levels of
training intensity (higher memory load vs. lower memory
load) and did not use the words “placebo,” “adaptive,” or
“non-adaptive.” However, we should note that because
parents served as the training aides, it is possible that
some surmised that their child was in the higher or lower
memory load group, despite the fact that they were not
exposed to the other training load condition. The parent
training aide was explicitly told not to help their child dur-
ing training (e.g., instructing them where to look or what
targets to press), although multiple methods of encourage-
ment and reinforcement were allowed. The two groups
completed 5–6 weeks of training 5 days a week to achieve
the goal of 25 total training sessions. After training (and
within 1 week of completion), the examiner returned to
the home to complete Time 2 assessments using the same
outcome measures. To examine whether improvements
related to Cogmed, if present, are maintained after train-
ing stops, examiners also completed a follow-up assess-
ment 3months later (Time 3). The same examiner
completed all assessments for each participant. All partici-
pants completed Cogmed training with their caregiver/
parent as the training aide, and the same training aide/par-
ent was present for all training sessions. All participants
received a weekly call by a staff member who com-
pleted coach training per Cogmed guidelines. Coaches
focused on working with parent training aides on
maintaining motivation (e.g., by making adjustments
to methods and type of reinforcement and utilizing a
picture schedule showing a timeline of training ses-
sions which could be crossed off ), dealing with any
technological problems, managing challenging behav-
iors, minimizing distractions in the environment, en-
couraging breaks in training when needed, and
adjusting time of day for training as needed to
maximize focus and compliance.
Working memory outcome measures
The Leiter-Revised (Leiter-R) Spatial Memory subtest
was used as one of two objective measurements of visual
WM. The Leiter-R is sensitive to visual WM impair-
ments in children/adolescents with FXS [3, 28]. For this
study, rather than counting one point per correct trial,
we calculated the total number of correctly recalled ob-
jects, allowing for greater range. The Stanford Binet 5
Block Span subtest requires the participant to watch the
examiner tap blocks in a particular order and then recall
the pattern by tapping the blocks in the same order. For
this study, we added several additional easier items, also
to allow greater range. The composite (average) of the
Spatial Memory and Block Span scores was used as the
primary and pre-specified outcome measure for this
trial. To measure auditory WM, the Wechsler
Intelligence Scale for Children, Fourth Edition (WISC-IV)
Digit Span subtest was used.
Executive Function Outcome Measures
The Kiddie Test of Attentional Performance (KiTAP [29])
is a computer-administered measure of EF designed
around an enchanted castle theme. A panel of seven
scores from four subtests was identified as feasible;
lacked ceiling, basal, or learning effects; exhibited an ac-
ceptable range; had good reproducibility; and correlated
significantly with ratings for hyperactivity and/or atten-
tion in our prior studies with FXS participants [29].
Behavioral Ratings of Attention and Executive Function
The Conners Third Edition (Conners 3 [30]) is a
multi-informant assessment of ADHD-related behavior
that takes into account home, social, and school settings.
The Behavior Rating of Executive Function (BRIEF [31])
is a standardized measure of behaviors related to EF for
children. Both caregivers and teachers provided Conners
and BRIEF ratings, using versions of the scales appropri-
ate for the participant’s mental age. The Inattention and
Hyperactivity/Impulsivity subscales of the Conners and
the WM and Global Executive Composite scales of the
BRIEF were used. Teacher ratings were not possible for
participants who had assessments during summer
months or for participants who were home-schooled.
Statistical analyses
The pre-specified efficacy analysis for the WM compos-
ite score was analysis of covariance (ANCOVA) of out-
come measures after 5–6 weeks of treatment adjusted
for baseline measures. Analyses of secondary measures
(BRIEF, Connors, KiTAP, and Digit Span) were also
based on the ANCOVA model, adjusted for baseline
measures. Secondary analyses (of both primary and sec-
ondary outcomes) to compare scores at baseline,
post-training, and 3-month follow-up were based on lin-
ear mixed effects model. Post hoc analyses were also
performed to examine the two versions of Cogmed sep-
arately (JM and RM). Additional post hoc descriptive
analyses compared “improved” and “not improved” par-
ticipants within adaptive and non-adaptive control
groups, using twice the average improvement over
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baseline (IOB) with respect to the primary outcome (vis-
ual working memory composite) as the cut-point to div-
ide these groups. All tests, except for primary efficacy,
were at a level of 0.05 and analyses were implemented in
SAS® software Version 9.4. Also, we examined the
test-retest reliability of the outcome measures in this
study sample in order to determine the stability of these
measurements in this population and to inform future
research. This was done using the intraclass correlation
coefficient (ICC) with data collected at the post-training
visit and the 3-month follow-up for all subjects.
Results
Participant characteristics at baseline
The adaptive and non-adaptive participant groups did
not differ significantly by race, ethnicity, parent educa-
tion level, household income, parent marital status, psy-
choactive medication use, age, abbreviated IQ, mental
age, or total number of Cogmed training days (Table 1,
descriptive statistics). Participants in the adaptive group
spent about 3 min more active training time per day
than those in the non-adaptive control group (p < .05).
Active training time was used as a covariate in analyses
below.
Cogmed working memory training Progress
As can be seen in Fig. 2, Cogmed JM adaptive partic-
ipants started training with a maximum span length
of just over 3.0 and improved modestly and steadily
to a maximum span of about 3.8 near the end of
training (mean Index of Improvement = 14.81). A
paired-samples t test showed a significant increase in
memory span between Start Index and Maximum
Index, t (31) = 13.45, p < .0001; Cohen’s d = 2.38.
Cogmed RM adaptive participants began at an ap-
proximately 4.2 span length and finished at a max-
imum of approximately 5.2 near the end of training
(mean Index of Improvement = 21.89). For the RM
group, a paired-samples t test also documented the
Table 1 Participant and parent characteristics by adaptive vs. non-adaptive control group
Variable Category Non-adaptive Adaptive p value
N % N %
Participant racea Caucasian 38 76.00 41 82.00 0.461a
Participant ethnicitya Hispanic or Latino 11 22.00 7 14.00 0.298a
Parent 1 education (training aide) a Bachelor’s or above 33 66.00 33 67.35 0.545a
Parent 2 educationa Bachelor’s or above 34 70.83 22 47.83 0.826a
Household income $75 K+ 34 69.39 29 59.18 0.237
<$75 K 10 20.40 15 30.61
Prefer not to report 5 10.20 5 10.20
Participant psychoactive medications SSRI/SNRI 21 42.00 21 42.00
Stimulant 14 28.00 22 44.00
Antipsychotic 3 6.00 6 12.00
Glutamatergic 3 6.00 1 2.00
GABAergic 1 2.00 0 0.00
Alpha agonist 2 4.00 2 4.00
Any 31 62.00 32 64.00 0.836
Parent marital status Married 46 92.00 46 93.88 0.511
Cogmed training platform PC with mouse 13 26.00 12 24.00 0.817
Tablet 37 74.00 38 76.00
Mean SD Mean SD p value
Participant age 12.26 3.04 13.00 3.11 0.232
Abbreviated IQ (SB 5) 64.79 15.64 64.42 17.73 0.914
Mental age equivalent (years; SB 5) 6.98 1.90 7.31 3.91 0.323
Cogmed sessions per week 4.46 0.83 4.38 1.09 0.710
Total training days 24.22 1.47 24.22 1.79 1.000
Active training time per day (min) 18.01 5.98 21.08 8.10 0.033
p values reflect differences utilizing all categories
aNot all categories are shown to conserve table space
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significant increase in memory span, t (17) = 17.74, p
< .0001; Cohen’s d = 2.62.
Visual working memory (primary outcome)
For the WM composite, the average score
post-training relative to baseline was slightly higher
for adaptive compared to non-adaptive groups, al-
though the baseline-adjusted group difference
post-training was not statistically significant (Table 2).
The linear effects mixed model showed that in both
adaptive and non-adaptive control training groups,
primary WM outcomes were significantly improved
post-training compared to baseline on both tests
(Table 3). Furthermore, improvements at 3-month
follow-up were maintained and similar to levels seen
at the completion of training (Table 3, 3-month
follow-up vs. post-training).
Auditory working memory (digit span)
Digit Span increased significantly in both treatment
groups after training (Table 3); however, the adaptive
group did not improve significantly more than the
Fig. 2 Maximum average working memory span length (index) by
training day in participants with fragile X syndrome completing adaptive
Cogmed JM (N= 32; blue) or RM (N= 18; red) training. JM and RM
participants showed significant increases in memory span between Start
Index and Maximum Index (JM, paired t (31) = 13.45, p< .0001, Cohen’s d
= 2.38; RM, paired t (17) = 17.74, p< .0001; Cohen’s d= 2.62). Error bars
show 95% confidence intervals
Table 2 Primary and secondary outcomes analyses (by treatment condition)a
Variables Non-adaptive control Adaptive p value
Baseline Post-training Baseline Post-training
N Mean SD N Mean SD N Mean SD N Mean SD
(A) Primary measures
Leiter-Revised Spatial Memory 50 21.44 10.00 49 22.94 9.87 50 20.44 14.09 49 24.27 13.51
Stanford Binet-5 Block Span 50 10.66 4.65 49 11.65 4.86 50 10.20 5.40 50 11.92 5.75
Visual Working Memory Composite (mean) 50 16.05 6.62 49 17.30 6.71 50 15.32 9.15 49 18.19 8.98 0.533
(B) Secondary measures
Digit Span (auditory working memory) 49 8.02 4.02 48 8.54 3.82 49 7.51 4.69 49 8.53 5.12 0.888
BRIEF
Parent—Working Memory 48 21.48 3.95 47 20.53 4.23 49 22.12 3.84 49 21.49 4.17 0.082
Teacher—Working Memory 28 21.57 5.65 23 20.83 5.59 31 23.13 5.26 30 21.70 5.84 0.313
Parent—Global Executive Composite 46 151.61 21.82 46 144.41 24.83 45 151.38 27.63 47 148.13 25.83 0.022
Teacher—Global Executive Composite 27 143.30 32.06 22 142.36 34.04 29 143.79 32.28 30 137.83 33.75 0.182
Conners
Parent—Inattention 47 17.98 5.88 46 16.67 6.72 49 18.80 6.32 49 17.53 6.95 0.527
Teacher—Inattention 28 18.32 9.11 25 16.20 8.03 31 18.07 8.30 30 15.80 8.52 0.499
Parent—Hyperactivity/Impulsivity 47 18.23 10.88 46 16.94 12.02 49 18.55 11.71 49 18.45 12.54 0.319
Teacher—Hyperactivity/Impulsivity 28 25.50 14.76 11 29.73 16.90 31 22.90 16.46 14 22.64 17.47 0.820
KiTAP
Distractibility Errors 43 16.84 11.02 40 14.83 11.58 40 15.35 10.27 41 13.29 11.38 0.920
Alertness SD of RT 48 240.18 266.98 45 230.40 206.09 45 344.76 294.35 47 309.77 286.70 0.189
Flexibility False Alarms 42 8.05 4.27 38 7.13 3.81 37 9.24 3.87 38 7.53 4.50 0.985
Go NoGo False Alarms 47 4.34 4.84 44 4.93 5.39 41 4.00 4.96 46 5.35 5.08 0.153
BRIEF Behavior Rating of Executive Function, SD standard deviation, RT reaction time, KiTAP Kiddie Test of Attentional Performance, GEC Global
Executive Composite
aResults adjusted for active training time
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Table 3 Linear mixed effect model comparison of outcomes over time (combined groups)
Outcome Comparison Estimates
Est. SD p value
(A) Primary outcomes
Leiter-Revised Spatial Memory PT vs. BL 2.62 0.85 0.003
FU vs. BL 2.21 0.89 0.014
FU vs. PT − 0.41 0.90 0.650
Stanford Binet-5 Block Span PT vs. BL 1.41 0.25 < .0001
FU vs. BL 1.36 0.26 < .0001
FU vs. PT − 0.05 0.26 0.856
(B) Secondary outcomes
Digit Span PT vs. BL 0.85 0.20 < .0001
FU vs. BL 1.30 0.21 < .0001
FU vs. PT 0.45 0.21 0.029
BRIEF
Parent—Working Memory PT vs. BL − 0.87 0.29 0.003
FU vs. BL − 0.74 0.30 0.015
FU vs. PT 0.13 0.30 0.668
Teacher—Working Memory PT vs. BL − 1.16 0.41 0.006
FU vs. BL − 1.90 0.54 0.001
FU vs. PT − 0.74 0.54 0.172
Parent—GEC PT vs. BL − 5.65 1.46 < .0001
FU vs. BL − 4.04 1.50 0.008
FU vs. PT 1.62 1.49 0.279
Teacher—GEC PT vs. BL − 4.93 2.45 0.048
FU vs. BL − 9.20 3.21 0.006
FU vs. PT − 4.27 3.19 0.185
Conners
Parent—Inattention PT vs. BL − 1.38 0.44 0.002
FU vs. BL − 0.80 0.45 0.080
FU vs. PT 0.58 0.46 0.203
Teacher—Inattention PT vs. BL − 2.03 0.70 0.005
FU vs. BL − 1.63 0.98 0.100
FU vs. PT 0.40 0.97 0.678
Parent—Hyperactivity/Impulsivity PT vs. BL − 0.76 0.56 0.179
FU vs. BL 0.16 0.58 0.787
FU vs. PT 0.91 0.58 0.118
Teacher—Hyperactivity/Impulsivity PT vs. BL − 0.69 1.02 0.498
FU vs. BL − 1.35 1.40 0.338
FU vs. PT − 0.65 1.39 0.639
KiTAP
Distractibility Errors PT vs. BL − 2.14 0.92 0.021
FU vs. BL − 1.64 1.05 0.119
FU vs. PT 0.50 1.04 0.631
Alertness SD of RT PT vs. BL − 20.11 24.98 0.422
FU vs. BL 19.57 28.10 0.487
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non-adaptive group (Table 2). The linear effects model
showed further significant improvement for both groups
after the 3-month follow-up for this measure.
Attention, inhibitory control and cognitive flexibility
(KiTAP)
For the KiTAP, overall participants made significantly
fewer false alarms on the Flexibility test at post-training
and follow-up compared to baseline, and significantly
fewer errors on the Distractibility test after training
(Table 3). Participants receiving adaptive training did not
significantly outperform those in the non-adaptive con-
trol group after treatment on any KiTAP test (Table 2).
Parent and teacher ratings of behavior and executive
function (Conners, BRIEF)
Parents and teachers reported significant reductions
in problems of attention, WM, and global EF between
baseline and post-treatment (Table 3), but no signifi-
cant differences in improvement were observed be-
tween treatment conditions (Table 2). Parents of
children in the adaptive group (compared to
non-adaptive) reported significantly less improvement
on the global executive score of the BRIEF. However,
neither parents nor teachers reported significant
changes in hyperactive/impulsive behaviors during the
treatment period for either group.
Post hoc analysis: examination of Cogmed JM and RM
training
Participant and demographic characteristics did not differ
between adaptive (A) and non-adaptive (NA) groups within
JM (Additional file 2: Table S1) or RM (Additional file 3:
Table S2), except for average active training time per day
similar to the overall cohort (Table 1). Between JM an RM
cohorts, participants in RM had higher mean IQ (NA 76.8,
A 79.6) than participants in JM (NA 58.3, A 55.9) and
higher mental age by ~ 3.5 years. Although total training
days were similar between JM and RM groups, as expected
the active training time per day (min) was greater in RM
(NA 24.8, A 30.8) than JM (NA 14.2, A 15.6). The JM group
had a higher proportion of Hispanic or Latino families and
lower proportion of higher education (Bachelor’s or above).
Separate models comparing adaptive and non-adaptive
control training for JM and RM versions revealed differ-
ent results with regard to the primary outcome measure,
the visual memory composite. For JM, the adaptive
group significantly outperformed the control group for
this near-transfer measure (Fig. 3); however, relative im-
provement of adaptive training did not generalize to
other domains of measurement for this subgroup (Add-
itional file 4: Table S3). There was a nearly (p = .053) sig-
nificant difference on the KiTAP Alertness test for JM,
however the control group reduced variability in reac-
tion time after training more so than the adaptive group.
RM training yielded no significant benefits of adaptive
over non-adaptive control training on any measure. For
RM, the non-adaptive group had a larger decrease in
parent-reported EF problems than the control group.
Post hoc analysis: examination of “improved” vs. “not
improved” participants
For the adaptive group, the average improvement over
baseline (IOB) with respect to the primary outcome
(visual working memory composite) was about 2
points. Thus, we defined “improved” as individuals
whose improvement was at least twice the average
IOB (i.e., improvement of 4 points or more) vs. “not
improved” as IOB < 4. Results are summarized in
Additional file 5: Table S4. Participant and parent
characteristics, including IQ, were not different be-
tween those who improved (n = 15) and did not im-
prove (n = 26). However, the group that improved on
average had one more training day (~ 25 vs. 24 days)
during the study. A similar analysis was conducted
for the control group (Additional file 6: Table S5).
Overall, there was no difference in characteristics be-
tween the groups that improved (n = 11) and did not
improve (n = 27), except that the group that improved
was older (13.6 vs. 11.7-years old). We caution that
Table 3 Linear mixed effect model comparison of outcomes over time (combined groups) (Continued)
Outcome Comparison Estimates
Est. SD p value
FU vs. PT 39.67 27.94 0.158
Flexibility False Alarms PT vs. BL − 1.37 0.39 0.001
FU vs. BL − 1.28 0.44 0.004
FU vs. PT 0.10 0.43 0.823
Go NoGo False Alarms PT vs. BL 1.02 0.46 0.030
FU vs. BL 0.62 0.53 0.240
FU vs. PT − 0.39 0.52 0.453
BRIEF Behavior Rating of Executive Function, PT post-training, FU follow-up, BL baseline, SD standard deviation, RT reaction time, KiTAP Kiddie Test of Attentional
Performance, GEC Global Executive Composite
Hessl et al. Journal of Neurodevelopmental Disorders            (2019) 11:4 Page 9 of 14
reader that these ad-hoc supplemental analyses are
descriptive and exploratory.
3-month test-retest reliability of outcome measures
The test-retest intraclass correlation coefficients for the out-
come measures are shown in Additional file 7: Table S6.
With the exception of the measure of Alertness on the
KiTAP test, stability during the 3-month follow-up was good
to excellent.
Discussion
The results of this controlled trial of working memory
training in children and adolescents with FXS showed
that objectively-evaluated WM and some domains of EF,
as well as parent- and teacher-reported attention and
EF-related behaviors significantly improved during the
treatment period, with many changes maintained at
follow-up after 3 months without training. However,
contrary to the primary study hypothesis, degree of im-
provement between adaptive treatment and control
groups did not differ significantly, showing that progres-
sively challenging the WM system by expanding span
length (which adaptive Cogmed participants were able
to achieve) did not provide added benefit in the full
range of individuals with this disorder.
A potential explanation for why improvements were
seen in both the non-adaptive control and adaptive
conditions is that the study is more an assessment of
dose of training, with the non-adaptive a “low level”
training, rather than a comparison of active versus
placebo conditions. Both conditions require active use
of WM processes, and other studies have demon-
strated improvements on objective outcome measures
in the non-adaptive condition [32, 33]. It may be that
the non-adaptive condition could have greater impact
on individuals with a relatively lower baseline level of
working memory functioning, for whom a typical
span length might be closer to 2–4 items capacity.
The non-adaptive condition level is set at a span
length of 2 items, which might be already close to
the maximum of what our participants with intellec-
tual disability were capable of and therefore be quite
challenging. Thus, detecting a significant difference
between the adaptive and non-adaptive condition
could be difficult given that this is more of a com-
parison between a low and high dose of training, and
in this regard a larger sample may be necessary to
detect a difference between two active treatments.
It is possible that the improvements seen in both
groups (adaptive and non-adaptive) reflect practice or
rater expectancy effects rather than changes associated
with training. In retrospect, it may have been helpful to
include a wait-list control group (especially for compari-
son to non-adaptive control), although this type of de-
sign has limitations as well, namely the comparison of
any treatment to none (lack of specificity) and contamin-
ation by uncontrolled placebo and expectancy effects
which are well known in trials of patients with FXS and
other neurodevelopmental disorders, particularly on the
subjective measures (i.e., rating scales). From the per-
spective of the performance measures, there is little if
any evidence from prior studies that cognitive scores of
Fig. 3 Composite visual memory score (a; primary outcome; mean of Leiter Spatial Span and SB-5 Block Span) and b auditory working memory score (WISC
IV Digit Span) at baseline, post-training, and at 3-month follow-up (no training), by Cogmed version (RM, higher functioning, N= 36; JM, lower functioning, N
= 64) and by treatment condition (adaptive, N= 50 vs. non-adaptive control, N= 50) in children and adolescents with fragile X syndrome. Adaptive and non-
adaptive groups combined demonstrated significant gains in visual and auditory working memory after training (p< .0001), and significant gains in auditory
working memory also continued after 3months of no treatment (p< .05). Post hoc analyses demonstrated significant improvement in the JM adaptive
compared to non-adaptive groups from baseline to post-training (a), but no relative difference in efficacy for the RM version. Scores are raw observed
scores ± SEM
Hessl et al. Journal of Neurodevelopmental Disorders            (2019) 11:4 Page 10 of 14
individuals with FXS improve significantly over a period
of weeks or months without intervention. For example,
in our work on the NIH Toolbox Cognitive Battery, 26
individuals with intellectual disability (ID) (including 10
with FXS) of approximately the same chronological and
mental ages (mean = 16 years and 5 years, respectively)
completed the List Sort WM test at baseline and after 4
weeks of no intervention and did not significantly im-
prove (p = .40, Cohen’s d = .17) [7]. There also were no
other significant improvements over that time span
on any of the other 6 subtests. In the prior work on
the KiTAP in 27 young adults with FXS retested after
2–4 weeks [29], there were no significant changes in
performance on the same 4 key measures utilized in
the present study. Finally, in other published work,
wait-list controls in the previously-described study of
the efficacy of Cogmed JM in children with DS
showed no significant improvement on performance
measures of verbal or visual-spatial short-term mem-
ory or WM [27]. In the DS study, participants had al-
most exactly the same gains on JM as our FXS adaptive
JM participants (Index of Improvement ~ 14). We
recognize that the data collected in these other studies
were collected under circumstances that differ from the
trial presented here. However, we felt that a comparison
of test-retest data from individuals with FXS and DS who
are not receiving treatment or intervention would be use-
ful in interpreting the present cognitive training results.
Placebo effects could explain the observed improve-
ments, and prior work suggests they may be seen even
on performance measures in persons with ID [34]. Thus,
it is important to try to evaluate the degree to which im-
provements seen in the present study are due to the
treatment itself vs. various other factors that may lead to
improvement such as attention to the participant, the
caregiver’s expectations of the treatment, and the partici-
pant’s own expectancy to improve through training.
Three results of the study suggest that placebo effects
are unlikely to fully explain the improvements. First,
many improvements during the course of training were
maintained after 3 months of no training, and in no case
did performance return to pre-training baseline. Second,
teachers reported significant improvements in WM, glo-
bal EF, and attention in another environment (school)
across both groups, and they were kept unaware of the
purpose of the study. And third, improvements were not
observed in all areas, suggesting that effects may be
more related to attention and EF. In particular, no sig-
nificant changes were seen in hyperactive/impulsive be-
havior and there was a significant increase in false
alarms on the KiTAP Go NoGo test after training. An-
other potential explanation for the improvements seen
in both adaptive and non-adaptive groups, is that a more
general process of regularly engaging in tasks that
require sustained attention, response inhibition,
remaining seated, following instructions, and pressing
on and completing a task over time, while guided by a
supportive training aide (parent, in this case), is thera-
peutic for individuals with FXS, who have
well-documented problems in all of these areas. Also, as
stated by Chacko and colleagues who also observed
gains associated with non-adaptive training [32], sup-
portive counseling and coaching of parents (a primary
role of the Cogmed coach) can contribute to reduced
ADHD symptoms (e.g., Sonuga-Barke et al. [35]). In this
regard, a non-therapeutic computer game with matched
active time and duration may have been helpful as a
contrast condition. If the “general structured training”
interpretation of the observed gains is correct, there may
be a range of parent-guided one-on-one cognitive and/
or behavioral training approaches that can be beneficial
to children with FXS. As such these results may have
implications for the design of future treatment studies.
Given the pattern of results in the study, a natural
question is: Is Cogmed an empirically validated treat-
ment for children and adolescents with FXS, forming
the basis for treatment recommendation? Unfortu-
nately, without a clear separation of the adaptive from
non-adaptive control groups (the a priori hypothesis)
or separation of Cogmed training from another in-
active control, it is not possible to draw this conclu-
sion, despite the possibility that both levels of
training may have contributed to the observed
changes. Also, for the primary outcome measures, the
effect sizes were modest, with Cohen’s d in the range
of .21–.31 for the adaptive group. For the teacher and
parent ratings, effect sizes were in the range of
.20–.27. Although certainly a challenge, future studies
examining cognitive training effects in ID populations
such as FXS will need to carefully consider and select
treatment comparison conditions to ensure the ab-
sence of an active control. Future analyses will help
to identify subgroups with the best response to treat-
ment, and in those cases effect sizes are likely to be
larger. Inter-individual differences (e.g., quality of
training, baseline capacity, co-morbidity, training en-
vironment, characteristics of training aide) may be as-
sociated with training outcomes and transfer effects
and may be particularly critical in populations with
ID [36]. If any of these key factors do moderate effi-
cacy, the results may help to link training to out-
comes and will help to identify those families that are
the best candidates for this type of intervention. In
the current study, baseline participant and family
demographic factors did not differ in those who dem-
onstrated substantial improvement on the primary
outcome measure; although, it is of potential interest
that the “improved” and “not improved” adaptive
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groups showed a modest but significant difference in
the number of training days completed. Finally, as no
other controlled trials of cognitive or behavioral inter-
ventions for FXS are available, it is difficult to deter-
mine whether alternative interventions have stronger
effects.
The limitations of the study include the lack of a sec-
ondary comparison group (wait-list control or clearly in-
active control), variation in the control of the training
environment (homes) and training aides (parents of
varying skill, nature of parent-child relationship), a
sub-optimal sample size for examining teacher-reported
results, and a lack of caregiver data on satisfaction with
the treatment approach. The males in the study were on
average somewhat higher functioning (mean abbreviated
IQ = 56.8) than the overall population of males with
FXS, and as such, it is important to recognize that lower
functioning individuals may not be able to engage in the
training. Another possible limitation of Cogmed, and
likely other forms of cognitive training, is that it cannot
be maintained indefinitely while providing adequate
interest and engagement. Other forms of empirically val-
idated treatment may need to be integrated with the in-
dividual’s repertoire of educational remediation and
therapies to maintain engagement and provide more
generalized and sustained benefits. Despite these limita-
tions, the project provides strong evidence that
well-controlled, home-based cognitive/behavioral trials
can be completed with reliable and valid endpoints in in-
dividuals with FXS, suggesting similar success can be
achieved in other populations with ID. The unusually
low drop-out rate (3/105 participants enrolled) lends
support to the feasibility and acceptability for this
intervention with this population; although, we
recognize that the participating families were rela-
tively high-functioning (as reflected by marital status
and income); as such, it may be that those from more
disadvantaged backgrounds or single-parent house-
holds would have lower adherence rates.
A next step in this research program would be to
evaluate whether cognitive training such as Cogmed or
other attention training programs [37] and potentially
beneficial effects on attention and EF can be accelerated
by targeted pharmacological treatment. This combined
approach fits with a model whereby targeted treatment
(e.g., to restore more normal synaptic transmission, per-
haps through improved balance of inhibitory and excita-
tory brain mechanisms) provides individuals with FXS
with an enhanced potential to learn and gain function
through intensive cognitive or behavioral therapy.
Conclusions
This study provides evidence that children and adoles-
cents with FXS can engage and make progress in an
intensive web-based working memory training program,
Cogmed, over a period of 5–6 weeks. However, the pri-
mary hypothesis that participants completing the publi-
cally available adaptive training versions of the program
will make significantly greater gains in standardized
measures of working memory than those completing a
non-adaptive “control” version was not confirmed; in
fact both groups improved significantly on a variety of
metrics. Future studies with a non-active control condi-
tion or larger sample sizes may be needed to determine
whether Cogmed itself, rather than the poten-
tially broader therapeutic aspects of the intervention, is
effective for this population.
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